Home
ZTS
ZTS News

Latest Zoetis Inc. (ZTS) News on October 18, 2025

Xeris Biopharma (XERS) Surges 14.2%: Is This an Indication of Further Gains?

Zacks

2 days ago

Xeris Biopharma (XERS) Surges 14.2%: Is This an Indication of Further Gains?

How Lenivia Approvals at Zoetis (ZTS) Have Changed Its Innovation Pipeline and Recurring Revenue Outlook

Simply Wall St.

3 days ago

How Lenivia Approvals at Zoetis (ZTS) Have Changed Its Innovation Pipeline and Recurring Revenue Outlook

MT Newswires

3 days ago

Zoetis Says Health Canada Approves Lenivia as Treatment for Osteoarthritis Pain in Dogs

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Business Wire

3 days ago

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again

Zacks

4 days ago

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

StockStory

4 days ago

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain

Zacks

5 days ago

Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain

Morningstar Research

5 days ago

Analyst Report: Zoetis Inc.

MT Newswires

5 days ago

Leerink Partners Adjusts Zoetis' Price Target to $152 From $153, Keeps Market Perform Rating

MT Newswires

7 days ago

Zoetis Wins EU Backing for Dog Osteoarthritis Drug Lenivia

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Business Wire

7 days ago

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable

Simply Wall St.

7 days ago

Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable

Zoetis Declares Fourth Quarter 2025 Dividend

Business Wire

8 days ago

Zoetis Declares Fourth Quarter 2025 Dividend

2 Magnificent Dividend Stocks to Buy Now and Hold Forever

Motley Fool

10 days ago

2 Magnificent Dividend Stocks to Buy Now and Hold Forever

Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks

Insider Monkey

10 days ago

Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks

My 2 Favorite Stocks to Buy Right Now

Motley Fool

13 days ago

My 2 Favorite Stocks to Buy Right Now

MT Newswires

15 days ago

TD Cowen Adjusts Price Target on Zoetis to $189 From $202, Maintains Buy Rating

Is Now the Right Moment to Reassess Zoetis After Recent FDA Approval News?

Simply Wall St.

15 days ago

Is Now the Right Moment to Reassess Zoetis After Recent FDA Approval News?

IDEXX Laboratories, Inc. (IDXX) Stock Delivers 97% Return in 3 Years, Outpacing Zoetis and Market

Insider Monkey

16 days ago

IDEXX Laboratories, Inc. (IDXX) Stock Delivers 97% Return in 3 Years, Outpacing Zoetis and Market

Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025

Insider Monkey

16 days ago

Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025

Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost

Insider Monkey

17 days ago

Phibro Animal Health Corporation (PAHC) Soars 39% in Q4, Stock Up 80% YTD on Zoetis Acquisition Boost

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Business Wire

17 days ago

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zacks

19 days ago

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

21 days ago

Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing

2 Oversold Stocks Primed to Rebound and 1 Facing Challenges

StockStory

22 days ago

2 Oversold Stocks Primed to Rebound and 1 Facing Challenges

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

StockStory

24 days ago

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela

Insider Monkey

24 days ago

EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

Business Wire

25 days ago

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

Zoetis (ZTS) Receives Positive Opinion from CVMP for Portela®

Insider Monkey

a month ago

Zoetis (ZTS) Receives Positive Opinion from CVMP for Portela®

Pet Diabetes Care Devices Market Trend Analysis and Forecast Report 2025-2034, with Profiles of Allison Medical, ALR Technologies, Boehringer Ingelheim, FitBark, TaiDoc, Ulticare, Zoetis, and More

GlobeNewswire

a month ago

Pet Diabetes Care Devices Market Trend Analysis and Forecast Report 2025-2034, with Profiles of Allison Medical, ALR Technologies, Boehringer Ingelheim, FitBark, TaiDoc, Ulticare, Zoetis, and More

Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors

Zacks

a month ago

Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors

Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain

Zacks

a month ago

Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain

MT Newswires

a month ago

BNP Paribas Exane Adjusts Zoetis Price Target to $223 From $226, Maintains Outperform Rating

Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief

Simply Wall St.

a month ago

Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief

MT Newswires

a month ago

Zoetis' Pain Relief Cat Medication Gets Recommendation for Marketing Approval in Europe

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Business Wire

a month ago

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Zacks

a month ago

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Zoetis Inc. (ZTS) Secures a New Five-Year $1.25 Billion Senior Unsecured Revolving Credit Facility

Insider Monkey

a month ago

Zoetis Inc. (ZTS) Secures a New Five-Year $1.25 Billion Senior Unsecured Revolving Credit Facility

Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why

Zacks

a month ago

Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why

Zoetis (ZTS) Fell in Line With Broader Health Care Sector

Insider Monkey

a month ago

Zoetis (ZTS) Fell in Line With Broader Health Care Sector

Argus Research

a month ago

Analyst Report: Zoetis Inc

Argus Research

a month ago

Market Digest: ZTS

ZTS- An Attractive Dividend Growth Play in the Animal Health Business

MoneyShow

a month ago

ZTS- An Attractive Dividend Growth Play in the Animal Health Business

Canine Cancer Screening Market Report 2025: IDEXX Laboratories, Zoetis, and Heska Corporation Lead this Rapidly Evolving Industry

GlobeNewswire

a month ago

Canine Cancer Screening Market Report 2025: IDEXX Laboratories, Zoetis, and Heska Corporation Lead this Rapidly Evolving Industry

Is Zoetis Stock Underperforming the Nasdaq?

Barchart

a month ago

Is Zoetis Stock Underperforming the Nasdaq?

Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand

Insider Monkey

2 months ago

Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand

If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now

Zacks

2 months ago

If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Business Wire

2 months ago

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

2 Reasons to Watch ZTS and 1 to Stay Cautious

StockStory

2 months ago

2 Reasons to Watch ZTS and 1 to Stay Cautious

Does Zoetis Offer Value for Investors After Its Recent Rebound in 2025?

Simply Wall St.

2 months ago

Does Zoetis Offer Value for Investors After Its Recent Rebound in 2025?

MT Newswires

2 months ago

Rothschild & Co Redburn Adjusts Price Target on Zoetis to $195 From $200, Maintains Buy Rating

Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory

2 months ago

Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

2 months ago

[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises

StockStory

2 months ago

ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises

5 Revealing Analyst Questions From Zoetis’s Q2 Earnings Call

StockStory

2 months ago

5 Revealing Analyst Questions From Zoetis’s Q2 Earnings Call

Global Veterinary Regenerative Medicine Market Size/Share Worth USD 1395.44 Million by 2034 at a 13.23% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

2 months ago

Global Veterinary Regenerative Medicine Market Size/Share Worth USD 1395.44 Million by 2034 at a 13.23% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

Motley Fool

2 months ago

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

MT Newswires

2 months ago

Zoetis Prices $1.85 Billion Debt Offering

Zoetis Announces Pricing of $1.85 Billion of Senior Notes

Business Wire

2 months ago

Zoetis Announces Pricing of $1.85 Billion of Senior Notes

If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today

Motley Fool

2 months ago

If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Zacks

2 months ago

SDZNY vs. ZTS: Which Stock Is the Better Value Option?

Are Wall Street Analysts Predicting Zoetis Stock Will Climb or Sink?

Barchart

2 months ago

Are Wall Street Analysts Predicting Zoetis Stock Will Climb or Sink?

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Zoetis to $215 From $210, Maintains Overweight Rating

2 Stocks to Buy With $5,000 and Hold for a Decade

Motley Fool

2 months ago

2 Stocks to Buy With $5,000 and Hold for a Decade

BofA Kept $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest

Insider Monkey

2 months ago

BofA Kept $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest

Zoetis Inc. Just Recorded A 5.8% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.

2 months ago

Zoetis Inc. Just Recorded A 5.8% EPS Beat: Here's What Analysts Are Forecasting Next

MT Newswires

2 months ago

Leerink Partners Adjusts Price Target on Zoetis to $153 From $155, Maintains Market Perform Rating

Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term

Zoetis Reverses And Dives As Its Arthritis Setback Continues

Investor's Business Daily

2 months ago

Zoetis Reverses And Dives As Its Arthritis Setback Continues

Morningstar Research

2 months ago

Analyst Report: Zoetis Inc.

Zoetis CFO talks Q2 beat & education's role in pet med adoption

Yahoo Finance Video

2 months ago

Zoetis CFO talks Q2 beat & education's role in pet med adoption

Zoetis Inc. (ZTS): A Bull Case Theory

Insider Monkey

2 months ago

Zoetis Inc. (ZTS): A Bull Case Theory

ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised

Zacks

2 months ago

ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised

Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline

Benzinga

2 months ago

Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline

Stocks See Support from Strong Earnings and Rate Cut Speculation

Barchart

2 months ago

Stocks See Support from Strong Earnings and Rate Cut Speculation

Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

2 months ago

Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zoetis Surges After Crushing Expectations And Raising Its Outlook

Investor's Business Daily

2 months ago

Zoetis Surges After Crushing Expectations And Raising Its Outlook

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand

Reuters

2 months ago

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand

Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates

Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars

StockStory

2 months ago

Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars

1 Top Dividend Growth Stock to Buy and Hold Forever

Motley Fool

2 months ago

1 Top Dividend Growth Stock to Buy and Hold Forever

MT Newswires

2 months ago

Zoetis Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Guidance

Associated Press Finance

2 months ago

Zoetis: Q2 Earnings Snapshot

Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

Business Wire

2 months ago

Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

Zoetis (ZTS) Reports Earnings Tomorrow: What To Expect

StockStory

2 months ago

Zoetis (ZTS) Reports Earnings Tomorrow: What To Expect

Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect

Zacks

3 months ago

Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect

Countdown to Zoetis (ZTS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks

3 months ago

Countdown to Zoetis (ZTS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Here's Why Zoetis (ZTS) Fell More Than Broader Market

Zacks

3 months ago

Here's Why Zoetis (ZTS) Fell More Than Broader Market

MT Newswires

3 months ago

Jefferies Adjusts Zoetis Price Target to $180 From $190, Maintains Buy Rating

Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

MT Newswires

3 months ago

Morgan Stanley Adjusts Price Target on Zoetis to $221 From $238

MT Newswires

3 months ago

Morgan Stanley Adjusts Price Target on Zoetis to $221 From $238, Maintains Overweight Rating

Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?

StockStory

3 months ago

Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?

USNA or ZTS: Which Is the Better Value Stock Right Now?

Zacks

3 months ago

USNA or ZTS: Which Is the Better Value Stock Right Now?

Winners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory

3 months ago

Winners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

Aristotle Atlantic’s Core Equity Strategy Sold Zoetis (ZTS) Due to Competition Concerns

Insider Monkey

3 months ago

Aristotle Atlantic’s Core Equity Strategy Sold Zoetis (ZTS) Due to Competition Concerns

Zoetis (ZTS) Laps the Stock Market: Here's Why

Zacks

3 months ago

Zoetis (ZTS) Laps the Stock Market: Here's Why

Here’s Wedgewood Partners’ Investment Thesis for Zoetis (ZTS)

Insider Monkey

3 months ago

Here’s Wedgewood Partners’ Investment Thesis for Zoetis (ZTS)

Share on Social Networks: